CYP4V2 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

44 results for “CYP4V2”

Trials

View all 39 →

Safety Study of rAAV2/8-hCYP4V2 in Patients With Bietti's Crystalline Dystrophy (BCD)

12 participants · First posted Jan 25, 2021

Personalized Nutrition Caffeine Intake in Healthy Adults.

94 participants · First posted Oct 10, 2019

Pharmacokinetics of the Basel Phenotyping Cocktail Combination Capsule

12 participants · First posted Aug 14, 2017

Drugs

Investigational

RBIO-101

rAAV2/8-hCYP4V2

CYP1A2 inhibitors (cancer)

News

Shanghai Vitalgen Advances VGR-R01 Gene Therapy to Phase 3 Trial for Bietti Crystalline Dystrophy

Gene Therapy NGGT001 Shows Promising Safety Profile in Bietti's Crystalline Dystrophy Trial

Page 1 of 5